Pharmaceutical form: Capsule

DRUG2 trials

Sponsors

Stichting Radboud universitair medisch centrum, Intas Pharmaceuticals Ltd

Conditions

Health Condition 1: C729- Malignant neoplasm of central nervous system, unspecifiedPosttraumatic Stress Disorder (PTSD)

Phase 4

Targeted glucocorticoid administration to improve safety learning in posttraumatic stress disorder patients with HPA axis dysregulation

Not yet recruitingCTIS2024-516427-13-00

Stichting Radboud universitair medisch centrumPosttraumatic Stress Disorder (PTSD)

Target: 190Updated: 2024-10-28

Unknown Phase

A study of Temozolomide Powder For Oral Suspension in Cancer Patients

Active, not recruitingCTRI/2021/04/032776

Intas Pharmaceuticals LtdHealth Condition 1: C729- Malignant neoplasm of central nervous system, unspecified

Target: 14Updated: 2022-10-17